CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
Sablinski
T
T
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Hancock
W W
WW
Schmidbauer
G
G
Milford
E L
EL
Kupiec-Weglinski
J W
JW
D000208:Acute Disease; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D015478:Antigens, Heterophile / Q000276:immunology*; D015704:CD4 Antigens / Q000276:immunology*; D006224:Cricetinae; D005434:Flow Cytometry; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D008647:Mesocricetus; D051381:Rats; D011917:Rats, Inbred Lew; D016176:T-Lymphocyte Subsets / Q000276:immunology; D014183:Transplantation, Heterologous / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015478:Antigens, Heterophile; D015704:CD4 Antigens